暂无分享,去创建一个
Rayid Ghani | John P. A. Ioannidis | Franz J. Király | Chris Holmes | Harry Hemingway | Sebastian Vollmer | Bilal A. Mateen | Gary S. Collins | Karel G. M. Moons | Gergo Bohner | Pall Jonsson | Sarah Cumbers | Adrian Jonas | Katherine S. L. McAllister | Puja Myles | David Granger | Mark Birse | Richard Branson | S. Vollmer | J. Ioannidis | G. Collins | R. Ghani | F. Király | K. Moons | H. Hemingway | K. McAllister | P. Myles | Adrian Jonas | P. Jónsson | B. Mateen | G. Bohner | Richard Branson | C. Holmes | Sarah Cumbers | M. Birse | David Granger | Mark Birse
[1] Andrew Zisserman,et al. Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.
[2] Been Kim,et al. Towards A Rigorous Science of Interpretable Machine Learning , 2017, 1702.08608.
[3] Tom Fahey,et al. Diagnostic accuracy of the STRATIFY clinical prediction rule for falls: A systematic review and meta-analysis , 2012, BMC Family Practice.
[4] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[5] Nitish Srivastava,et al. Improving neural networks by preventing co-adaptation of feature detectors , 2012, ArXiv.
[6] Gary S Collins,et al. Comparing risk prediction models , 2012, BMJ : British Medical Journal.
[7] Stephen Walker,et al. Nonparametric learning from Bayesian models with randomized objective functions , 2018, NeurIPS.
[8] David Moher,et al. Reducing waste from incomplete or unusable reports of biomedical research , 2014, The Lancet.
[9] Roger G. Mark,et al. Reproducibility in critical care: a mortality prediction case study , 2017, MLHC.
[10] D. Curtis. Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia , 2018, bioRxiv.
[11] John P A Ioannidis,et al. Diagnostic tests often fail to lead to changes in patient outcomes. , 2014, Journal of clinical epidemiology.
[12] E. Steyerberg,et al. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.
[13] John P. A. Ioannidis,et al. An empirical assessment of validation practices for molecular classifiers , 2011, Briefings Bioinform..
[14] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[15] Laura W. Harris,et al. A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog , 2018, Genome Biology.
[16] Franz J. Király,et al. NIPS - Not Even Wrong? A Systematic Review of Empirically Complete Demonstrations of Algorithmic Effectiveness in the Machine Learning and Artificial Intelligence Literature , 2018, ArXiv.
[17] S. Astley,et al. Single reading with computer-aided detection for screening mammography. , 2008, The New England journal of medicine.
[18] Richard D Riley,et al. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes , 2013, BMJ : British Medical Journal.
[19] J. Robson,et al. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.
[20] Geraint Rees,et al. Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.
[21] S. Tamang,et al. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data , 2018, JAMA internal medicine.
[22] Jeffrey Dean,et al. Scalable and accurate deep learning with electronic health records , 2018, npj Digital Medicine.
[23] Stephen Evans,et al. Medicines and Healthcare Products Regulatory Agency (MHRA) (Formerly MCA) , 2005 .
[24] Irene Dankwa-Mullan,et al. Concordance assessment of a cognitive computing system in Thailand. , 2017 .
[25] Won-Suk Lee,et al. Use of a cognitive computing system for treatment of colon and gastric cancer in South Korea. , 2017 .
[26] J. Ioannidis,et al. Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.
[27] Cody Agnellutti. Big data : an exploration of opportunities, values, and privacy issues , 2014 .
[28] Christine L. Borgman,et al. On the Reuse of Scientific Data , 2017, Data Sci. J..
[29] T. Freer,et al. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. , 2001, Radiology.
[30] Stephen Fenlon,et al. The anaesthetist and the Medicines and Healthcare products Regulatory Agency , 2012 .
[31] Carlos Guestrin,et al. "Why Should I Trust You?": Explaining the Predictions of Any Classifier , 2016, ArXiv.
[32] P. Royston,et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.
[33] Iain Chalmers,et al. How to increase value and reduce waste when research priorities are set , 2014, The Lancet.
[34] Iveta Simera,et al. The EQUATOR Network: Enhancing the quality and transparency of health research through the use of reporting guidelines , 2008 .
[35] Matt J. Kusner,et al. Counterfactual Fairness , 2017, NIPS.
[36] David Moher,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.
[37] John P. A. Ioannidis,et al. How to Make More Published Research True , 2014, PLoS medicine.
[38] John P. A. Ioannidis,et al. What does research reproducibility mean? , 2016, Science Translational Medicine.
[39] Chris Russell,et al. Counterfactual Explanations Without Opening the Black Box: Automated Decisions and the GDPR , 2017, ArXiv.
[40] C. Lehman,et al. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. , 2015, JAMA internal medicine.
[41] G. Collins,et al. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting , 2014, BMC Medical Research Methodology.
[42] F. Cabitza,et al. Unintended Consequences of Machine Learning in Medicine , 2017, JAMA.
[43] Igor F Tsigelny,et al. Artificial intelligence in drug combination therapy , 2019, Briefings Bioinform..
[44] Patrick M M Bossuyt,et al. Waste, Leaks, and Failures in the Biomarker Pipeline. , 2017, Clinical chemistry.
[45] K. Covinsky,et al. Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.
[46] J. Ioannidis,et al. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. , 2015, Journal of clinical epidemiology.
[47] Ran D Balicer,et al. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study , 2017, British Medical Journal.
[48] Rayid Ghani,et al. Aequitas: A Bias and Fairness Audit Toolkit , 2018, ArXiv.
[49] G. Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement , 2015, Annals of Internal Medicine.
[50] Rustam Al-Shahi Salman,et al. Increasing value and reducing waste in biomedical research regulation and management , 2014, The Lancet.
[51] Benjamin Neale,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .
[52] R. Tibshirani,et al. Increasing value and reducing waste in research design, conduct, and analysis , 2014, The Lancet.
[53] Eugenio Culurciello,et al. An Analysis of Deep Neural Network Models for Practical Applications , 2016, ArXiv.
[54] Yvonne Vergouwe,et al. Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.
[55] Lei Liu,et al. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients , 2016, PLoS medicine.
[56] George Athanasopoulos,et al. Forecasting: principles and practice , 2013 .
[57] B. Frémont,et al. SUMMARY OF SAFETY AND EFFECTIVENESS DATA , 2002 .
[58] Piotr Sliz,et al. A Quick Guide to Software Licensing for the Scientist-Programmer , 2012, PLoS Comput. Biol..
[59] S. Uchino,et al. Prediction Models and Their External Validation Studies for Mortality of Patients with Acute Kidney Injury: A Systematic Review , 2017, PloS one.
[60] Elizabeth Ford,et al. “Giving something back”: A systematic review and ethical enquiry into public views on the use of patient data for research in the United Kingdom and the Republic of Ireland , 2018, Wellcome open research.
[61] D J Torgerson,et al. Pragmatic trials: lab meets bedside , 2019, The British journal of dermatology.
[62] Jesse A. Berlin,et al. Assessing the Generalizability of Prognostic Information , 1999 .
[63] Jon F. Claerbout,et al. Electronic documents give reproducible research a new meaning: 62nd Ann , 1992 .
[64] H. Pashler,et al. Editors’ Introduction to the Special Section on Replicability in Psychological Science , 2012, Perspectives on psychological science : a journal of the Association for Psychological Science.
[65] T. Nolan,et al. The NHS heart age test will overload GPs who are already under huge pressure , 2018, British Medical Journal.
[66] Matthew Willetts,et al. Statistical machine learning of sleep and physical activity phenotypes from sensor data in 96,220 UK Biobank participants , 2017, Scientific Reports.
[67] Julia Fu,et al. Next steps for IBM Watson Oncology: Scalability to additional malignancies. , 2014 .
[68] Y Ramya,et al. Abstract S6-07: Double blinded validation study to assess performance of IBM artificial intelligence platform, Watson for oncology in comparison with Manipal multidisciplinary tumour board – First study of 638 breast cancer cases , 2017 .
[69] Harlan M Krumholz,et al. Increasing value and reducing waste: addressing inaccessible research , 2014, The Lancet.